<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02934009</url>
  </required_header>
  <id_info>
    <org_study_id>11-014</org_study_id>
    <nct_id>NCT02934009</nct_id>
  </id_info>
  <brief_title>Dermal Profile Analysis Using the NMR-MOUSE</brief_title>
  <acronym>SHN</acronym>
  <official_title>Dermal Profile Analysis Using NMR-MOUSE (Nuclear Magnetic Resonance - Mobile Universal Surface Explorer)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lehrstuhl für Makromolekulare Chemie, RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The determination of fluid status in dialysis patients is a major clinical problem. In this
      study the NMR-MOUSE is used to determine if it can be used to non-invasively determine
      hydration status of the skin. This evaluation will be performed in dialysis patients and
      healthy volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Excretion of urine is impaired in terminal chronic kidney disease patients often requiring
      dialysis. Fluid management of dialysis patients is solely based on body weight differences
      before and after dialysis. Patients can suffer from either hypotension if too much fluid is
      eliminated by dialysis or from fluid-overload symptom (e.g. shortness of breath, edema) if
      not enough fluid is eliminated.

      In this study a mobile non-invasive NMR-MOUSE setup (a nuclear magnetic resonance
      spectroscopy measurement) is used to measure the hydration status of the skin.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of the diffusion coefficient D [m²/s] by NMR-MOUSE in dialysis patients and healthy volunteers</measure>
    <time_frame>30 minutes</time_frame>
    <description>The skin will be subjected to a weak magnetic field (B0). The transversal relaxation time T2 [in s] will be measured stepwise in mm (millimeter) profiles for up to 16 mm depth in the skin. From the different measurements per profile of the skin a diffusion coefficient D [m²/s] will be calculated, which changes dependent on the hydration status of the skin.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] of NMR-Mouse dermal measurement</measure>
    <time_frame>30 minutes</time_frame>
    <description>The overall number of participants with treatment-related adverse events during the study will be investigated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time needed for NMR-Mouse dermal measurement</measure>
    <time_frame>30 minutes</time_frame>
    <description>The overall time needed to measure each participant of the study will be documented.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">85</enrollment>
  <condition>Exposure to Magnetic Field</condition>
  <condition>Hypotension During Dialysis</condition>
  <condition>Disturbance; Balance, Fluid</condition>
  <arm_group>
    <arm_group_label>Dialysis patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group dialysis patients are measured by NMR-Mobile Universal Surface Explorer® (NMR-Mouse) during their routine dialysis sessions. After a 5 min rest period the arm of the patients is placed onto the NMR-Mouse and measured before the beginning of dialysis. The arm examined is not the shunt arm. The area selected should not display any signs of skin disease or scars from previous surgeries. After the dialysis the same area is measured again in a second measurement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group &quot;kidney-healthy&quot; volunteers will be examined by NMR-Mobile Universal Surface Explorer® (NMR-Mouse) at three different days. The right/left arm or leg will be used for repeated measurement. Altogether 2 measurements per day are reformed in order to evaluate the reproducibility and variability.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dermal nuclear magnetic resonance (NMR)-profile measurement</intervention_name>
    <description>Nuclear magnetic resonance (NMR)-profile measurement of the dermis</description>
    <arm_group_label>Dialysis patients</arm_group_label>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <other_name>NMR-MOUSE</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-80

          -  Dialysis

          -  ability to perform NMR-measurement

          -  Eligibility to sign informed consent

          -  signed informed consent

        Exclusion Criteria:

          -  implanted cardiac device

          -  implanted cranial device

          -  implanted cochlea device

          -  intrauterine device

          -  other metallic implants

          -  tattoo, any skin disease or scars from surgery (in the area of measurement)

          -  previous skin treatment with cosmetics (of any kind) 24 hours prior to measurement

          -  wearing of earrings, piercings or hearings-aids during measurement

          -  participation in other clinical trials 30 days prior to participation in the SHN study

          -  no written informed consent

          -  any conditions, as determined by the examiner, that excludes the patient from
             participation in the study

          -  subjects with legal guardian

          -  pregnancy or lactation (a possible pregnancy of a participant before menopause will be
             excluded before inclusion in the study)

          -  subjects under employment or with any relation to the the sponsor or the investigator

          -  participation in any other study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jürgen Floege, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christoph Kuppe, M.D.</last_name>
    <phone>0049-0241-80</phone>
    <phone_ext>37308</phone_ext>
    <email>ckuppe@ukaachen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christina Grohe, B. Sc.</last_name>
    <phone>00490241-80</phone>
    <phone_ext>35849</phone_ext>
    <email>cgrohe@ukaachen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of RWTH Aachen, Department of Medicine II</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jürgen Floege, Prof. Dr. med.</last_name>
      <phone>+49 241 80</phone>
      <phone_ext>89530</phone_ext>
      <email>juergen.floege@rwth-aachen.de</email>
    </contact>
    <contact_backup>
      <last_name>Christoph Kuppe, Dr. med.</last_name>
      <phone>+49 241 80</phone>
      <phone_ext>37308</phone_ext>
      <email>ckuppe@ukaachen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Jürgen Floege, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christoph Kuppe, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Boor, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Perlo J, Casanova F, Blümich B. Profiles with microscopic resolution by single-sided NMR. J Magn Reson. 2005 Sep;176(1):64-70.</citation>
    <PMID>15975840</PMID>
  </reference>
  <reference>
    <citation>Danieli E, Blümich B. Single-sided magnetic resonance profiling in biological and materials science. J Magn Reson. 2013 Apr;229:142-54. doi: 10.1016/j.jmr.2012.11.023. Epub 2012 Dec 8. Review.</citation>
    <PMID>23290626</PMID>
  </reference>
  <reference>
    <citation>Perlo J, Casanova F, Blümich B. Single-sided sensor for high-resolution NMR spectroscopy. J Magn Reson. 2006 Jun;180(2):274-9. Epub 2006 Mar 31.</citation>
    <PMID>16580238</PMID>
  </reference>
  <reference>
    <citation>Medrano G, Eitner F, Floege J, Leonhardt S. A novel bioimpedance technique to monitor fluid volume state during hemodialysis treatment. ASAIO J. 2010 May-Jun;56(3):215-20. doi: 10.1097/MAT.0b013e3181d89160.</citation>
    <PMID>20404719</PMID>
  </reference>
  <reference>
    <citation>Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ; Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005 Jan;45(1):142-61. Epub 2004 Dec 20.</citation>
    <PMID>15611362</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2016</study_first_submitted>
  <study_first_submitted_qc>October 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2016</study_first_posted>
  <last_update_submitted>July 3, 2017</last_update_submitted>
  <last_update_submitted_qc>July 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

